Skip to main content

This content is exclusively provided by FAO / FAOLEX / ECOLEX

The present National Action Plan on Antimicrobial Resistance (NAP-AMR) reflects the European and international objectives on informed use of antibiotics. It comprises human medicine concerns as well as veterinary activities, animal husbandry, the food chain and the environment. The goal is to secure a lasting reduction in the emergence and spread of antimicrobial resistance, so as to maintain the effectiveness of available antimicrobial substances and enhance the quality of antimicrobial therapies. Moreover, the Plan establishes that prescribing antimicrobials indiscriminately, using them incorrectly or failing to respect the correct treatment duration can also encourage the development of resistance. Pathogen resistance has direct health consequences, since it can have a detrimental impact on the effectiveness of anti-infectives and thus hinder the treatment of infectious diseases in humans, farm animals, pets and other small animals.
In particular, the Plan s goal is to promote general awareness and understanding, as well as joint action as follows: 1) Solutions to diminish the problem of resistance must include measures relating to both outpatient and inpatient care (general practitioners, hospital facilities), in addition to the veterinary and food sectors. 2) The primary objective must be a lasting reduction in the emergence and spread of antimicrobial resistance. This requires proper use of anti-infectives and rigorous hygiene. 3) Strategic objectives include the coordination of activities, the reinforcement of surveillance networks, the implementation of measures to prevent and combat the spread of resistant pathogens by providing the necessary structures, and the promotion of prudent use of anti-infectives. 4) Ongoing information campaigns must be put in place to raise public awareness of the risks posed by antimicrobial resistance and its consequences for public health.
There are several activities relating to antimicrobial resistance (AMR) carried out by the Austrian Federal Ministry of Health. The work in the human and veterinary medicine sectors is coordinated by the Federal Ministry of Health's AMR platform. This platform provides a forum for discussion of the annual national Reports on antimicrobial resistance and the work of the various sectors involved.
Authorisation and market surveillance of proprietary medicinal products (for human and animal use) by the Austrian Federal Office for Safety in Health Care and other licensing authorities in Europe: In the framework of the authorisation procedure for proprietary medicinal products (including proprietary antimicrobial products), the experts at each of the competent licensing authorities examine the effectiveness, safety and quality of the proprietary medicinal product for which the authorisation has been requested and decide based on the available risk-benefit balance whether to grant an authorisation. When assessing proprietary medicinal products for animals, the environmental risk is also taken into account. Authorisation is followed by proactive monitoring of the proprietary medicinal products (pharmacovigilance). The Federal Ministry of Health is addressing the challenge of antimicrobial resistance and has already put in place some important measures: 1) Under the Austrian national initiative on tackling antimicrobial resistance (NI-AMR) the main challenges in the area of human medicine have been addressed by five working groups (Surveillance; Hygiene and Infection Prevention; 'Antimicrobial Stewardship' (= the rational use of antibiotics); Diagnosis of Infectious Diseases; and Reporting and Information). The groups have called on the knowledge and experience of an Austria-wide team of experts from a range of disciplines and professions, comprising both practitioners and academics. The findings of these working groups in the human medicine area are presented in the 'human medicine' section of the 'National Action Plan on Antimicrobial Resistance (NAPAMR). The section of the action plan entitled 'Measures from the veterinary medicine and environment discipline' presents the strategy on fighting antimicrobial resistance and maintaining the effectiveness of antibiotics for human and animal use in that subject area.
The text consists of 4 Parts as follows: Introduction (1): Initial position (1.1); International measures to maintain the efficacy of antibiotics in humans and animals (1.2); National measures to maintain the efficacy of antibiotics in humans and animals (1.3). Human health (2); Procedure (2.1); Surveillance (2.2); Hygiene and prevention of infection (2.3); Antimicrobial stewardship (2.4); Diagnosis of infectious diseases (2.5); Reporting and information (2.6); Science and research (2.7); Nursing homes and other health care facilities (2.8); Further actions (2.9); Literature (2.10). Measures from the field veterinary medicine and the environment (3); Procedure (3.1); Programme (3.2); Authorization of antibiotics (3.3); Recording (3.4); Prudent use of antibiotics (3.5); Austrian Animal Health Service (3.6); Food chain (3.7); Fire blight in Austria (3.8); Antibiotic residues in the environment (3.9).; References (3.10); Participants (3.11). Further actions (4),
National Action Plan on Antibiotic Resistance.
Type of document:
Date of text:
Data source: